Karachi: Liven Pharma Limited has announced the successful commissioning of a new Automatic Ampule Washing Machine at its manufacturing facility, as disclosed on December 23, 2025. The integration of this machine marks a significant development in the company’s operational capabilities, according to the disclosure of material information in line with Clause 5.6.1(a) of PSX Regulations and Section 96 of the Securities Act, 2015.
The new equipment, now fully operational, is expected to enhance production efficiency by approximately 20-25%. This improvement is largely attributed to faster processing and enhanced consistency standards in the ampoule preparation process. The installation is also anticipated to decrease manual intervention, lower rejection rates, and boost overall operational reliability.
According to information available from the Pakistan Stock Exchange (PSX), the commissioning of the Automatic Ampule Washing Machine represents a material change in Liven Pharma Limited’s manufacturing and operational capacity. This development could significantly impact the company’s future production volume and operational performance.
The integration of this automated equipment is expected to support higher throughput and better compliance with quality standards. As a result, it may also influence investor expectations and share trading dynamics, reflecting the company’s commitment to improving its production processes and operational efficiency.
This announcement is part of Liven Pharma Limited’s ongoing efforts to enhance its manufacturing capabilities and maintain competitive standards in the pharmaceutical industry. The company has requested that the TRE Certificate Holders of the Exchange be informed accordingly.